Sign in / Join Now
ETFs & Funds
conference call nugget, 80% of patients screened for entry into NEXUS trial are rejected due to strict criteria
Add a reply...
Latest StockTalks »
people get APEN breaking news and analysis by email alert.
Get email alerts on APEN »
Get latest price
From other sites
Apollo Endosurgery Appoints Dr. Christopher J. Gostout As Chief Medical Officer
at TheStreet (Jan 17, 2017)
Apollo Endosurgery Completes Merger With Lpath; Initiates Trading On NASDAQ As 'APEN'
at TheStreet (Dec 29, 2016)
Apollo Endosurgery And Lpath Sign Merger Agreement
at TheStreet (Sep 8, 2016)
Why is Lpath (LPTN) Stock Skyrocketing Today?
at Zacks.com (Jun 20, 2016)
Lpath Reveals 1-For-14 Reverse Stock Split
at Benzinga (Jun 9, 2016)